Ob. Petersen et al., THE EFFECTS OF DIHYDRALAZINE, LABETALOL AND MAGNESIUM-SULFATE ON THE ISOLATED, PERFUSED HUMAN PLACENTAL COTYLEDON, British journal of obstetrics and gynaecology, 101(10), 1994, pp. 871-878
Objective To assess the effects of dihydralazine, labetalol and magnes
ium sulphate on the vascular tone in the isolated, perfused human plac
ental cotyledon.Methods In vitro perfusion of the fetal compartment of
isolated, human placental cotyledons. Results None of the drugs affec
ted basal vascular tone. The thromboxane A(2)-mimic U46619 and endothe
lin-1 induced a concentration-dependent increment in perfusion pressur
e, while 5-hydroxytryptamine induced a variable increase, and norepine
phrine induced a small, transient increase in perfusion pressure. Afte
r preconstriction with U46619, magnesium sulphate (1.5 x 10(-3) to 6 x
10(-3) mol/l) induced a decrease in perfusion pressure, while dihydra
lazine (10(-6) to 10(-4) mol/l) or labetalol (10(-7) to 10(-4) mol/l)
enhanced the perfusion pressure. These effects of dihydralazine and la
betalol were unaffected by treatment with indomethacin 10(-6) mol/l, b
ut could be reversed by addition of magnesium sulphate 6 x 10(-3) mol/
l. Labetalol 10(-6) to 10(-4) mol/l also caused an increase in the per
fusion pressure induced by endothelin-1, but showed no effects after p
reconstriction with 5-hydroxytryptamine. Pretreatment with labetalol 1
0(-4) mol/l inhibited the transient increase in perfusion pressure ind
uced by norepinephrine 3 x 10(-5) mol/l. Conclusions The present data
demonstrated that the commonly used vasodilating agents labetalol and
dihydralazine do not produce vasodilatation in the human perfused coty
ledon after vasoconstriction induced by agents of suggested importance
for maintenance of fetal placental vascular tone, and that high conce
ntrations of these drugs may even enhance vasoconstriction induced by
thromboxane and endothelin-1 in this area. Magnesium sulphate may show
the potential to reverse such unwanted effects of dihydralazine and l
abetalol.